These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 32229190)
1. Oncogenic HBV variants and integration are present in hepatic and lymphoid cells derived from chronic HBV patients. Lau KC; Joshi SS; Gao S; Giles E; Swidinsky K; van Marle G; Bathe OF; Urbanski SJ; Terrault NA; Burak KW; Osiowy C; Coffin CS Cancer Lett; 2020 Jun; 480():39-47. PubMed ID: 32229190 [TBL] [Abstract][Full Text] [Related]
2. The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets. Ringelhan M; O'Connor T; Protzer U; Heikenwalder M J Pathol; 2015 Jan; 235(2):355-67. PubMed ID: 25196558 [TBL] [Abstract][Full Text] [Related]
3. Hepatitis B Virus Pregenomic RNA in Hepatocellular Carcinoma: A Nosological and Prognostic Determinant. Halgand B; Desterke C; Rivière L; Fallot G; Sebagh M; Calderaro J; Bioulac-Sage P; Neuveut C; Buendia MA; Samuel D; Féray C Hepatology; 2018 Jan; 67(1):86-96. PubMed ID: 28802063 [TBL] [Abstract][Full Text] [Related]
4. Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection. Tatsuno K; Midorikawa Y; Takayama T; Yamamoto S; Nagae G; Moriyama M; Nakagawa H; Koike K; Moriya K; Aburatani H Clin Cancer Res; 2019 Oct; 25(20):6217-6227. PubMed ID: 31320595 [TBL] [Abstract][Full Text] [Related]
5. Comprehensive review of Hepatitis B Virus-associated hepatocellular carcinoma research through text mining and big data analytics. Lee WY; Bachtiar M; Choo CCS; Lee CG Biol Rev Camb Philos Soc; 2019 Apr; 94(2):353-367. PubMed ID: 30105774 [TBL] [Abstract][Full Text] [Related]
6. Complete genome sequencing and clinical analysis of intrahepatic hepatitis B virus cccDNA from HCC. Jiao F; Long L; Ding S; Xie X; Jia L; Lu F Microb Pathog; 2017 Aug; 109():49-55. PubMed ID: 28478205 [TBL] [Abstract][Full Text] [Related]
7. Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma. Sukowati CH; El-Khobar KE; Ie SI; Anfuso B; Muljono DH; Tiribelli C World J Gastroenterol; 2016 Jan; 22(4):1497-512. PubMed ID: 26819517 [TBL] [Abstract][Full Text] [Related]
8. Noninvasive chimeric DNA profiling identifies tumor-originated HBV integrants contributing to viral antigen expression in liver cancer. Chen W; Zhang K; Dong P; Fanning G; Tao C; Zhang H; Guo S; Wang Z; Hong Y; Yang X; Lai S; Ding H; Zhao H; Zeng C; Protzer U; Zhang D Hepatol Int; 2020 May; 14(3):326-337. PubMed ID: 32100258 [TBL] [Abstract][Full Text] [Related]
10. Conceptual models for the initiation of hepatitis B virus-associated hepatocellular carcinoma. Tu T; Budzinska MA; Shackel NA; Jilbert AR Liver Int; 2015 Jul; 35(7):1786-800. PubMed ID: 25640596 [TBL] [Abstract][Full Text] [Related]
11. [Identification of hepatitis B virus integration sites in hepatocellular carcinoma tissues from patients with chronic hepatitis B]. Tu H; Gao HF; Ma GH; Liu Y Zhonghua Yi Xue Za Zhi; 2006 May; 86(18):1249-52. PubMed ID: 16796883 [TBL] [Abstract][Full Text] [Related]
12. Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma. Wong DK; Huang FY; Lai CL; Poon RT; Seto WK; Fung J; Hung IF; Yuen MF Hepatology; 2011 Sep; 54(3):829-36. PubMed ID: 21809355 [TBL] [Abstract][Full Text] [Related]
13. Viral integration drives multifocal HCC during the occult HBV infection. Chen XP; Long X; Jia WL; Wu HJ; Zhao J; Liang HF; Laurence A; Zhu J; Dong D; Chen Y; Lin L; Xia YD; Li WY; Li GB; Zhao ZK; Wu K; Hou Y; Yu JJ; Xiao W; Wang GP; Zhu PC; Chen W; Bai MZ; Jian YX; Kristiansen K; Chen Q J Exp Clin Cancer Res; 2019 Jun; 38(1):261. PubMed ID: 31200735 [TBL] [Abstract][Full Text] [Related]
14. Single-Nucleotide Resolution Mapping of Hepatitis B Virus Promoters in Infected Human Livers and Hepatocellular Carcinoma. Altinel K; Hashimoto K; Wei Y; Neuveut C; Gupta I; Suzuki AM; Dos Santos A; Moreau P; Xia T; Kojima S; Kato S; Takikawa Y; Hidaka I; Shimizu M; Matsuura T; Tsubota A; Ikeda H; Nagoshi S; Suzuki H; Michel ML; Samuel D; Buendia MA; Faivre J; Carninci P J Virol; 2016 Dec; 90(23):10811-10822. PubMed ID: 27681123 [TBL] [Abstract][Full Text] [Related]
15. Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review). He X; Li J; Wu J; Zhang M; Gao P Mol Med Rep; 2015 Nov; 12(5):6405-14. PubMed ID: 26398702 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus and hepatocellular carcinoma. Arbuthnot P; Kew M Int J Exp Pathol; 2001 Apr; 82(2):77-100. PubMed ID: 11454100 [TBL] [Abstract][Full Text] [Related]
17. Promoting effect of hepatitis B virus on the expressoin of phospholipase A2 group IIA. Zhu C; Song H; Shen B; Wu L; Liu F; Liu X Lipids Health Dis; 2017 Jan; 16(1):5. PubMed ID: 28077172 [TBL] [Abstract][Full Text] [Related]
18. Differential integration rates of hepatitis B virus DNA in the liver of children with chronic hepatitis B virus infection and hepatocellular carcinoma. Huang HP; Tsuei DJ; Wang KJ; Chen YL; Ni YH; Jeng YM; Chen HL; Hsu HY; Chang MH J Gastroenterol Hepatol; 2005 Aug; 20(8):1206-14. PubMed ID: 16048568 [TBL] [Abstract][Full Text] [Related]
20. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk. Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]